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Abstract
Multidetector row computed tomography (MDCT) is increasingly
taking a central role in identifying subphenotypes within chronic
obstructive pulmonary disease (COPD), asthma, and other lung-
related disease populations, allowing for the quantification of the
amount and distribution of altered parenchyma along with the
characterization of airway and vascular anatomy. The embedding
of quantitative CT (QCT) into a multicenter trial with a variety of
scanner makes and models along with the variety of pressures
within a clinical radiology setting has proven challenging,
especially in the context of a longitudinal study. SPIROMICS
(Subpopulations and Intermediate Outcome Measures in COPD
Study), sponsored by the National Institutes of Health, has
established a QCT lung assessment system (QCT-LAS), which
includes scanner-specific imaging protocols for lung assessment
at total lung capacity and residual volume. Also included are
monthly scanning of a standardized test object and web-based
tools for subject registration, protocol assignment, and data
transmission coupled with automated image interrogation to
assure protocol adherence. The SPIROMICS QCT-LAS has been
adopted and contributed to by a growing number of other
multicenter studies in which imaging is embedded. The key
components of the SPIROMICS QCT-LAS along with evidence of
implementation success are described herein. While imaging
technologies continue to evolve, the required components of a
QCT-LAS provide the framework for future studies, and the
QCT results emanating from SPIROMICS and the growing
number of other studies using the SPIROMICS QCT-LAS
will provide a shared resource of image-derived pulmonary
metrics.
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Quantitative computed tomography (QCT)
of the lung has been used to assess, as
demonstrated in Figure 1, the presence and
extent of emphysema, air trapping, and
airway structural characteristics in patients
with chronic obstructive pulmonary disease
(COPD) and other lung diseases, including
asthma (1–5), and there is an emerging
interest in vascular quantification (6–8).
There are several large multicenter studies
of both COPD and asthma that include
QCT to evaluate changes in the lung,
including the Multi-Ethnic Study in
Atherosclerosis (MESA) Lung Study (9),
the Evaluation of COPD Longitudinally to
Identify Surrogate Endpoints (ECLIPSE)
study (10), the Genetic Epidemiology of
COPD study (COPDGene) (11), the
Canadian Cohort of Obstructive Lung
Disease (CanCOLD) study (12), and the
Severe Asthma Research Program
(SARP) (13).
The Sub-Populations and Intermediate
Outcome Measures in COPD Study
(SPIROMICS) was established to collect
and analyze CT image, pulmonary
function, biomarker, genomic, proteomic,
and clinical data from smokers with and
without COPD to identify subpopulations
and intermediate outcome measures in
patients with COPD (14). SPIROMICS
incorporates QCT data to assess
parenchymal, airway, and vascular-based
metrics. Participants are seen at 12
university-based clinical centers from
across the United States.
QCT of the lung depends on accurate,
precise, and repeatable CT images with
attenuation measurements of the lung
expressed in Hounsfield units (HU) (15, 16).
Quantitative measures of emphysema are
obtained at total lung capacity (TLC) as the
percentage of voxels less than 2950 HU,
and quantitative measures of air trapping
are extracted from images obtained
at residual lung volume (RV) as the
percentage of voxels less than 2856 HU.
In other studies, air trapping has been
assessed at FRC (17, 18). However, to meet
pulmonary function test standards for the
definition of air trapping, RV was selected
for assessment of air trapping. Airway
geometry is also assessed for metrics
including luminal area, wall area and
percentage wall area, segment lengths,
branch angles, airway branch patterns, and
more. The accuracy of the measurements is
based on computer algorithms dependent
on the accuracy of the CT Hounsfield unit
measurements as well as the spatial
resolution associated with both the scanner
itself and the image reconstruction
methods. To assure accurate measurements
across study sites, there are critical factors a
scanning protocol must consider, including
radiation exposure, spatial and temporal
resolution, reconstruction kernel, subject
Lung and Lobes
Emphysema
PRM Normal PRM fSAD PRM emph
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Labeled Airways
Figure 1. Components of a quantitative computed tomography evaluation. Emphysema is determined
as voxels falling below 2950 Hounsfield units (HU) on a total lung capacity (TLC) image data set, and air
trapping is determined as voxels falling below2856 HU on a residual volume (RV) image. Upper left panel
shows the components of the lung and airway segmentation, including the identification of individual
lobes, and the upper right inset to the upper left panel shows the lobar color coding. These colors are
used also in the middle row panels depicting low-attenuation clusters defining emphysema and air
trapping–like lung regions. The upper right panel demonstrates the airway segmentation and the blow-up
demonstrates the airway segment labeling. Five standardized paths of the airway tree are evaluated
passing through RB1, RB4, RB10, LB1, and LB10. In the lower panel is demonstrated the output from
what has been termed a parametric response map (PRM) (43, 44). After image matching of TLC and RV
images, voxels that are emphysema on TLC are eliminated from the voxel count of air-trapped regions,
thus leaving a modified map of which voxels are normal, air trapped (dubbed “functional small airways
disease” [fSAD]), and emphysema-like (emph), again on the basis of a 2950 and 2856 HU threshold.
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positioning within the CT scanner bore,
breath-holding techniques, and the
monitoring of the CT scanner calibrations.
For the reasons outlined here, the
SPIROMICS Radiology Committee
developed and implemented a QCT lung
assessment system (QCT-LAS) that includes
a standardized imaging protocol and a
data collection methodology. Imaging was
performed at baseline and at the 1-year
follow-up visit. This perspective describes
the steps taken to establish a CT imaging
protocol that reduces radiation dose
while assuring sensitive and accurate
quantification of parenchymal density as
well as airway and vascular geometry;
providing similar image quality across CT
scanner makes, models, and site; and
monitoring the data collection process. This
study represents the state of the art for a
snapshot of time. As scanner technologies
evolve to provide higher-quality image data
at further reductions in radiation doses
(19–21), the protocol provided will most
certainly evolve, but the images generated
from the protocol outlined here set a
baseline quality standard.
Implementation of Lung
Imaging Standards in
SPIROMICS: A Multicenter
CT Protocol
Radiation Dose
Scanners of different makes and models
deliver differing photon counts to the
subjects for a given milliamperage3
seconds (mAs) because of factors including
differences in beam filtration, variances in
tube potential, and rotation times. Thus,
a fixed milliamperage yields different
exposures, leading to noise differences
and inconsistencies in Hounsfield unit
measurements across scanners. The
SPIROMICS imaging protocol uses a
CT dose index for the scanned volume
(CTDIvol) to standardize exposure across
scanners, recognizing that the scanner-
reported CTDIvols are an average across a
given make and model and not exact values
for the particular scanner. To meet a target
CTDIvol, milliamperage is varied across
scanners, whereas the peak kilovoltage
can be fixed. For the scanners available
at the time of SPIROMICS recruitment,
implementations of these guidelines are
shown in Tables 1 and 2. Subject size was
assessed via use of the body mass index
(BMI) (14). In SPIROMICS, three BMI
ranges were selected for the establishment
of radiation doses. If the subject changed
BMI on visit 2 by more than 3 units on
either side of the BMI range for a given
exposure, the milliamperage was shifted
to the more appropriate dose level.
Radiation dose was further minimized
by scanning no more than 2 cm cephalad
of the lung apex or 5 cm caudal of the
lung base. Adherence was monitored at
the SPIROMICS Radiology Center
(University of Iowa), with deviation
reports sent when limits were exceeded.
With recent advances in dose modulation,
whereby milliamperage is continuously
adjusted for regional body structure,
noise settings can be established and
automatically maintained with
appropriate standardization.
Spatial and Temporal Resolution
Cross-scanner spatial resolution
equivalence was achieved by identifying
detector collimation and slice parameters
that provided similar submillimeter slice
thicknesses. Slice collimation, using the
maximum detector width (64 channels or
higher), was set at z0.6 mm to keep scan
speed high but still allow for thin slice
reconstructions (Table 2). Scan times
influence temporal resolution and are a
function of detector width, which differs
between scanners, X-ray tube detector
array rotation time, and pitch. Near-
equivalent scan times were achieved by
setting rotation time to 0.5 s and pitch
to 1.0 (Table 2).
Reconstruction Kernels
Reconstruction kernels have significant
impact on QCT measures (15). Current
QCT recommendations to assess lung
density and airway geometry use a medium
sharp reconstruction kernel. This led to the
selection of the Philips B, GE Standard,
and Siemens B35 kernels (see Figure E1A
in the online supplement). High spatial
frequency kernels, which have been popular
for visual assessments of the lung, alter
Hounsfield units at edges. This is problematic
when seeking accurate measures of regional
attenuation and consistent measures of
airways (Figure E1B). However, recent sharp
kernels provide distinct edges without
exaggerated contrast differences (22, 23).
Steps to Assure Quality Control in a
Multicenter Study
QCT-LAS eliminates the use of paper forms
and was developed to satisfy the need for
data collect in “real time,” essential in
multicenter, longitudinal imaging trials.
The QCT-LAS (Figure 2) reduces human
intervention and allows web-based software
automation of the workload. The steps
outlined in Figure 2 are critical and are
performed in a specific order to facilitate
QCT-LAS database monitoring of both
personnel and scanners.
Step 1: personnel training and
certification. SPIROMICS established an
integrated training method for coordinators
and technologists using QCT-LAS. Training
occurs before scanning onset and involves a
Manual of Procedures review, PowerPoint
review, imaging forms review, and a video
demonstration of the CT acquisition and
data entry procedures. Technologists and
coordinators are certified and provided with
a unique name and password for the
QCT-LAS on passing module-associated
quizzes. Privileges can be revoked by
consensus of the Radiology Committee
and Site Primary Investigator, with
reinstatement requiring recertification.
Table 1. Computed Tomography Radiation Standardization
Scan Type Body Habitus BMI Range CTDIvol (mGy)
Inspiration Obese .30 11.4
Inspiration Normal 20–30 7.6
Inspiration Below normal ,20 6.1
Expiration Obese .30 6.1
Expiration Normal ,30 4.2
Expiration Below normal ,30 4.2
Definition of abbreviations: BMI = body mass index; CT = computed tomography;
CTDIvol = volumetric computed tomography dose index.
CT dose is standardized so each manufacturer and model is matched within 63% of the target
CTDIvol. Adjustments to delivered dose were made on the basis of BMI ranges. Expiration radiation
exposure uses the same CTDIvol for both normal and below-normal body sizes.
PULMONARY PERSPECTIVE
796 American Journal of Respiratory and Critical Care Medicine Volume 194 Number 7 | October 1 2016
Written directions for the technologist
(Appendix 1A and 1B) accompany the
patient and include instructions to: (1)
position the subject at the center of the CT
scanner aperture by use of laser beams for
left-to-right and ventral-to-dorsal
centering, (2) scan only the z-axis length
needed to include the apical to basal extent
of the lungs, (3) select the display field of
view (DFOV) limited to the most lateral
extents of the lungs (providing maximal
spatial resolution) at TLC and to keep the
DFOV the same for TLC (inspiratory
volume) and RV (expiratory volume). A
consistent DFOV across lung volumes and
longitudinally is important for comparison
of airway and density metrics.
Breathing/breath-hold instructions
(Appendix 2) are supplied within the CT
technologist form, and technologists are
instructed to coach the subject, as in a
pulmonary function testing laboratory, to
achieve both TLC and RV with a series of
proceeding deep inspirations. Recorded
instructions should not be used, as this
takes the technologist’s attention off of
the subject.
At the time of training, it is emphasized
that positioning of the patient in the
isocenter of the CT scanner aperture is
critical, as discussed in the report from the
American College of Radiology (ACR) CT
accreditation program (24). Isocenter
positioning serves to reduce cone-beam and
scatter artifacts.
Step 2: CT scanner calibration status.
SPIROMICS requires that each scanner pass
an initial calibration check. Scanners must
have 64 detector rows or higher to provide
imaging speeds adequate for a breath-hold.
Precertified scanner information must also
be preloaded into the QCT-LAS before
onset of subject imaging. Each CT
manufacturer has their own scanner-specific
test object (“phantom”) that assesses the
calibration of several general scanner
parameters, such as the value of water that
should be 0 HU. The SPIROMICS CT
protocol includes a specialized CT test
object (referred to as the “COPDGene 1”
test object) developed in the COPDGene
study (25). Assurance of measurement
stability of a given CT scanner is critical to
any quantitative CT effort. If test object
Hounsfield unit values shift by more than
3 HU in any material, the site is alerted
and action is taken. Guidelines have been
developed for the automated assessment of
the appropriate positioning of the test
object within the scanner to assure that
object misalignment is not contributing to
measured deviations (26).
Step 3: Scan acquisition and data
entry. SPIROMICS developed Procedural
Verification Software (PVS) to provide
scanner information and track scan data in
real time (Figure E2A). PVS provides an
automated web portal system requiring a
local computer and Internet connection.
The main function of PVS is to provide
a mechanism for subject registration
before scanning and to provide the study
coordinator with subject- and scanner-
specific scan parameters from the QCT-LAS
database using the subject’s BMI. In a
longitudinal study, such as SPIROMICS,
PVS assures that follow-up scans match the
baseline scan in terms of scan protocol,
including scanning on the same scanner.
Details are provided in the online
supplement.
Table 2. Scanner-Specific Protocol Settings
Scanner Make Siemens Siemens Siemens GE GE Philips
Scanner model Definition (AS Plus)
128 slice
Definition (DS) 64 slice Sensation
64 slice
VCT 64 slice/
Discovery STE
Discovery CT
750HD 64 slice
Brilliance 64 slice
Scan type Spiral Spiral single source Spiral Helical Helical - standard Spiral helix
Scan FOV No selection No selection No selection Large Large No selection
Rotation time, s 0.5 0.5 0.5 0.5 0.5 0.5
Detector configuration 1283 0.6 643 0.6 643 0.6 643 0.625 643 0.625 643 0.625
Pitch 1.0 1.0 1.0 0.984 0.984 0.923
kVp 120 120 120 120 120 120
Inspiration (TLC) Effective mAs Effective mAs Effective mAs mA mA mAs
Small 90 85 80 145 145 105
Medium 110 105 100 180 180 130
Large 165 150 145 270 270 190
Expiration (RV) Effective mAs Effective mAs Effective mAs mA mA mAs
Extra small 60
Small 55 50 100 100 70
Medium/large 90 85 80 145 145 105
Dose modulation Care dose off Care dose off Care dose off Auto mA off Auto mA off Dose right (ACS) off
Standard algorithm B35 B35 B35 Standard Standard B
Lung algorithm B30 B31 None Detail Detail YB
Additional image filters No selection No selection No selection No selection IQ enhance off Adaptive filtering off
Thickness, mm 0.75 0.75 0.75 0.625 0.625 0.67
Interval, mm 0.5 0.5 0.5 0.5 0.5 0.5
Iterative reconstruction (noise
reduction algorithm)
Do not use IRIS Do not use IRIS No selection Do not use ASIR Do not use ASIR Do not use iDOSE
Scan time, 30-cm length, s ,10 ,10 ,10 ,10 ,10 ,10
Reconstruction mode N/A N/A N/A Plus Plus N/A
Smart mA N/A N/A N/A Off Off N/A
Definition of abbreviations: ACS = automatic current selection; ASIR = adaptive statistical iterative reconstruction; CT = computed tomography; FOV = field
of view; IQ = intelligent quantitation; IRIS = iterative reconstruction in image space; kVp = peak kilovoltage; mAs =milliamperage seconds; N/A = not
applicable; RV = residual volume; TLC = total lung capacity.
Standardizing on volumetric computed tomography dose index, protocols were developed for each scanner type within SPIROMICS (Subpopulations and
Intermediate Outcome Measures in COPD Study) so as to maximize the similarity of image data across sites. At each of the two lung volumes, the CT
protocol specifies the scanner model, scan mode, scan FOV, rotation time, detector configuration, pitch, kVp, mAs, dose modulation setting,
reconstruction kernels, post-processing filter settings, slice thickness, slice interval, iterative reconstruction algorithm setting, scan time for 30-cm length,
reconstruction mode, smart mA setting, and IQ enhance setting. Effective mAs represents the tube current–time product.
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Step 4: Image data transfer. Image
transfer software is critical to ensure timely
CT scan data transmission. The DICOM
Selection Parser and Transfer Check
(DISPATCH) software shown in Figure E3
provides an automated system that imports
scan data at the clinical center and exports
data to the Radiology Center via the Internet
in a secure manner. At the same time,
DISPATCH allows for the automated and
customized interrogation of the image’s
DICOM header for protocol evaluation.
Details are provided in the online
supplement.
Image Analysis
Image data generated through SPIROMICS
are being analyzed via VIDA Diagnostics’
Apollo software (VIDA Diagnostics,
Coralville, IA), and a data dictionary for
both density-based and airway metrics
is provided in Table E1. Researchers
interested in using SPIROMICS should
consult the “Obtaining SPIROMICS
data” tab on the study web site at
www.spiromics.com.
Evidence of Successful
Standardization
Scan Protocol Standardization
Results
Scanners have remained within 4 HU from
baseline for internal and 3 HU for external
air measurements (Figure 3). Most scanners
were stable (<2 HU) for internal and
external air, except for an apparent 4-HU
shift in the external air for scanner COL02.
This issue was detected by QCT-LAS, and
the site was alerted via email shortly after it
occurred. Using the test object data, a
service call was initiated, which included
scanner recalibration. Scanner repair was
followed by an acceptable test object scan,
and the scanner was placed back on the
approved list. Another scanner, UCLA03,
exhibited a 3-HU shift in internal air
measures over a 3-month period, and the
same steps were implemented; however,
the issue was resolved without a
service call.
SPIROMICS Quality Control Results
Deployment of QCT-LAS in July 2011
resulted in a significant reduction in
protocol errors, including radiation
dose deviations. Using QCT-LAS in the
first year we identified that 20% of the
subjects scanned (n = 995 subjects) had
protocol exceptions. Only 4.0% of these
exceptions involved deviations related to
radiation dose. This percentage dropped
QCT-LAS SYSTEM OVERVIEW
User:
Enters Study ID
Software:
Identifies approved
scanner
Software:
Provides
CT parameters
Software:
Supplies (printable)
parameters for the user
to take to CT
User:
Prints form and logs off
the system
CT Scan
User:
Logs on and enters CT
data, loads data into
the system
Software:
Checks CT DICOM
Software:
Sends verification
e-mail scans were
recieved
Software:
Sets up data from
administrator review
Software:
Check volumes
differences between
TLC and RV
Software:
Categorizes data for
analysis
User:
Done if data is OK.
Software:
Monitors personnel
certification
Software:
Reports number QC of
errors per site
Software:
Provides QC reports on
technologists
Software:
Ensures correct
subjects receive a CT
Figure 2. Flow diagram of quantitative computed tomography–lung assessment system (QCT-LAS) demonstrating important data checks completed
through web-based interaction of web-based software, limiting the site user to 3 basic steps and allowing the software to automatically handle 10 or more
steps. CT = computed tomography; DICOM= digital imaging and communication in medicine format; QC = quality control; RV = residual volume; TLC =
total lung capacity.
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from 20 to 11% scanned (n = 1,275
subjects) the following year. Of this 11%,
only z1% were related to deviations in
radiation dose. The z50% decrease in
protocol exceptions was attributed to the
ability of QCT-LAS to locate the problem
quickly and get the scans re-reconstructed
with the correct parameters while the
raw data were still available on the
scanner. Use of the system has allowed
site coordinators to become more familiar
with imaging parameters, which in turn
contributed to the 75% reduction in scan
deviations the following year.
In Figure 4, the repeatability of total
lung volumes, air volumes, and tissue
volumes (nonair volume consisting of
parenchymal blood plus tissue) at TLC
(Figure 4, top row) and RV (Figure 4,
bottom row) are demonstrated. Of 978
subjects in this early analysis, RV volume
was larger than the respective TLC volume
at either baseline or Year 1 in 26 subjects.
Because these breath holds were clearly
incorrect, these subjects were eliminated
from the baseline–Year 1 comparison.
These subjects clustered at a small number
of sites. Technicians were identified and
retrained. The remaining 952 subjects
(1,904 scans) are represented in Figure 4.
We visually reviewed all of the TLC and RV
scans for which the air volumes at visit 2
varied by more than 20% of the visit 1
values. This amounted to 13% of the 1,904
scans. A trained analyst reviewed these
“outliers” with visit 1 and visit 2 images
displayed side by side, along with their
overlaid lung segmentations. Results from
these reviews are tabulated in Table 3.
There were 80 outliers at TLC and 163 at
RV, indicating that it was more difficult
to attain and hold an RV versus a TLC
lung volume. All Apollo-derived lung
segmentations were found to be visually
accurate for the TLC scans, and only
two scans had previously undetected
segmentation issues on RV requiring
intervention. Figure 4 illustrates that
despite the relatively small numbers of
outliers at TLC or RV, the total lung, total
air, and total tissue volume repeatability
at visit 2 was strong. Because tissue volume
should remain constant across lung
inflation levels (except for small blood
volume changes), one would expect tissue
volume across visits and across lung
volumes to remain tight, despite variability
in breath hold repeatability. This is what
the data demonstrate. The linear
regressions for all comparisons displayed in
Figure 4 demonstrated an R2 greater than
0.80 (P, 0.0001).
Total tissue volume at TLC dropped
(visit 22 visit 1) a mean of 25.326 44 ml
(P = 0.0002) (95% confidence interval,
62.84 ml) suggesting an overall
progression of emphysema detectable in
a 1-year period. From the RV data, total
air volume change (visit 22 visit 1)
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Figure 3. These figures summarize the parameters and frequency that the Genetic Epidemiology of COPD (COPDGene) test object was scanned to
ensure computed tomography scanner calibration. Scanners have remained stable within 3 Hounsfield units from baseline. COPD = chronic obstructive
pulmonary disease.
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demonstrated a mean increase of 35.26
469 ml (P = 0.02) (95% confidence interval,
630 ml), suggesting an overall increase in
air trapping detectable in a 1-year period.
Further explorations of these data are
warranted to differentiate between
nonprogressors and rapid progressors. The
wide range represents the ranges both of
body habitus and lung sizes associated with
COPD. Of note, there was one subject with a
volume mismatch, but this subject also had
extremely large total air volumes both at
visit 1 and visit 2 (near 10 L; see lower panels
of Figure 4). The midcoronal sections from
visit 1 and visit 2 are depicted in Figure 5,
demonstrating very large apical bullae
contributing to the large lung volume but
also a clearly different RV effort between
visits 1 and 2, as seen in the lower panels.
Note the lack of separation of the heart
from the diaphragm in the lower left panel
and the clear separation in the lower right.
Discussion
The SPIROMICS CT protocol addresses the
important issues in performing QCT of the
lung for multicenter trials using CT scanners
from multiple manufacturers and/or
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Figure 4. Computed tomography (CT) volume comparisons Years 1 and 2. Comparison of total lung volume (left column), total air volume (middle
column), and total tissue volume (right column) at both total lung capacity (TLC) (top row) and residual volume (RV) (bottom row) in the first 952 subjects
with baseline and Year 1 image analysis data.
Table 3. Visual Assessment of Residual Volume and Total Lung Capacity Visit 1 to 2 Volume Outliers
Scan
Type
No. of Subjects with
>20% V2DAir Volume
Motion or Metal
Artifacts*
Large
BMI Changes*
Cases with Comorbidities Such as
Fibrosis, Paralyzed Diaphragm,
Lung Surgeries, etc.*
Mismatched Subjects
(V1 vs. V2)*
TLC 80 18 1 3 1
RV 162 18 1 3 1
Definition of abbreviations: BMI = body mass index; RV = residual volume; TLC = total lung capacity; V1 = visit 1; V2 = visit 2.
Results of visual assessment of RV and TLC data sets found to have .20% V2 air volume difference relative to baseline V1 values.
*Scans that were found to have visibly apparent differences beyond what would be expected from disease progression and beyond a simple mismatched
breath hold (V2 vs. V1).
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multiple models. In addition, using the
SPIROMICS CT protocol, normative values
for a large nonsmoking study population
have been developed as part of the MESA
Lung Study (27), thus yielding normative
values appropriate for other studies using
the SPIROMICS CT protocol.
A number of factors, long advocated for
use in QCT of COPD and asthma (15), have
been included in the SPIROMICS protocol.
These include use of a test object for
scanner calibration, minimizing radiation
dose, maximizing spatial and temporal
resolution through the use of MDCT
scanners, scanning at coached TLC for the
assessment of emphysema, scanning at a
coached RV for the assessment of air
trapping, and use of similar cross-
manufacturer reconstruction kernels. Use
of a specialized CT test object designed to
evaluate the calibration of the CT scanner
at the CT attenuation of normal lung tissue
is important for assuring meaningful CT
attenuation measurements. Currently, there
are no Food and Drug Administration
standards for Hounsfield unit precision in
the air/lung tissue range. However, the
ACR CT standards recommend air to be
21,0006 30 HU and water to be 06 7 HU
when using a certified ACR test phantom
(24). Although these numbers suit most
current clinical applications, they are not
precise enough for the lung QCT described
here. QCT of the lung requires tighter
precision (<3 HU) (28–30).
Minimizing radiation exposure in CT
must always be a goal. Use of fixed CTDIvol
dose is an improvement over recent trials
that used a fixed milliamperage3 seconds,
delivering a radiation dose based on
CTDIvols, adjusted for BMI, and achieving
similar image quality across subject sizes.
This method is similar to dose-modulation
techniques, where the X-ray beam contours
to the body to maintain a constant
noise level and will adjust based on the
attenuation of the anatomy (31, 32). At the
time of establishing the SPIROMICS
protocol, validation was absent for the
use of scanner-specific dose-modulation
techniques in QCT measures. More
recently, updates to dose modulation have
demonstrated good quantitative results and
should be considered in the future.
When new CT advancements are
developed, test objects provide a mechanism
for ensuring longitudinal stability in the
integrity of the QCT lung measurements
(25). Relevant test object studies have
shown that new CT technologies, such as
iterative reconstruction, have the potential
to further reduce radiation dose by 50 to
70% (33–35). Recent studies have shown
similar results in the COPDGene test
object using current iterative reconstruction
algorithms and detector technology (21).
Using emerging technologies, exposure for
a QCT scan can be reduced to that of a
posterior–anterior and lateral digital chest
radiographic examination (20).
The selected reconstruction kernels
(Siemens B35f and its equivalents, GE
standard and Phillips B kernels) are in
keeping with those used in the COPDGene
study (25). However, newer high spatial
resolution reconstruction kernels have been
released that avoid artificially enhanced
density differences at sharp edges while
maintaining edge sharpness. These sharper
kernels are under evaluation (22).
Written instructions regarding breath-
hold techniques for the patient assure that
CT scans are obtained at either TLC or
RV after assuring a constant volume history
via several deep inspirations. Accurate
breath holds remove the largest source of
lung density variability. Recent studies have
attempted to correct for inadequate lung
volumes, but there is no substitute for a
correct breath-hold effort (36–40).
The complexities of a multicenter
study with longitudinal time points are
significantly more challenging than single-
center studies with small patient numbers
(41). Using a QCT-LAS, incorporating
web-based components, provides less lag
time, which is critical to provide QC
feedback to a particular site and achieve the
overall goals of the study. Timely study
transmission to the Radiology Center and
feedback to the clinical center ensure that
sites can react to resolve issues quickly.
Clinical scanners are able to store raw
projection data for approximately 1 week.
Therefore, it is essential to address QC
issues (reconstruction kernel, DFOV, etc.)
during this time frame. Approximately
80% of QCT data sets with QC errors
requiring raw data for error correction
have been successfully corrected due to
prompt identification and notification of
Visit 1
TLC
RV
Visit 2
Figure 5. The midcoronal computed tomography sections from visits 1 and 2 of the subject
associated with the outlying data points observed on the residual volume (RV) plots of total lung
volume and total air volume in the lower left and middle panels of Figure 4 are shown here. The large
bullae contributed to very large total air volumes both at total lung capacity (TLC) (visit 1 = 10.5 L;
visit 2 = 10.9 L) as well as RV (visit 1 = 8.8 L; visit 2 = 10.8 L). The RV efforts between visit 1 and visit 2
are clearly different both quantitatively and as visually evaluated. Note the separation of the heart and
diaphragm on visit 2 but not visit 1.
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deviations using the QCT-LAS system in
SPIROMICS.
While CT technology rapidly advances,
manufacturers strive to maintain the ability
to translate QCT measures from one
scanner generation to the next. Deviations
in air values associated with scatter artifacts
are understood (42), and newer scanners
have made corrections. Improved iterative
reconstruction algorithms are emerging
with radiation exposure levels now
reaching that of a posterior–anterior and
lateral digital chest radiographic study
(20), increasing the utility of QCT in
longitudinal studies. However, accuracy of
longitudinal data critically depends on
careful data acquisition at each time point,
such as is provided for the SPIROMICS
QCT-LAS.
Conclusions
In establishing the SPIROMICS imaging
methodology, efforts were taken to establish
a protocol that would resolve numerous
issues identified in association with other
multicenter studies. Having established the
SPIROMICS protocol, it was adopted by
the MESA Lung Study and the SARP and
iteratively revised through investigator
feedback. The SPIROMICS CT protocol is
a well-optimized lung QCT protocol
suitable for multicenter studies of COPD
and asthma that involve scanning on
scanners of various models from multiple
manufacturers. The entire package of
protocol development, phantom scanning,
having a web-based tracking mechanism,
and sending CT scan data via an Internet-
based DICOM checking system is critical to
large multicenter studies. n
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Appendix 1
(A and B) Computed tomography (CT) technologist instruction forms. These forms provide information to ensure the technologists have all the proper
information to complete the examinations within the guidelines of the study. The forms are made available through the Procedural Verification Software
web system and may be downloaded and printed to take to the scanner room or used for study reference. ALARA = as low as reasonably achievable;
DFOV = display field of view; mAs =milliamperage seconds; RV = residual volume; TLC = total lung capacity.
PULMONARY PERSPECTIVE
804 American Journal of Respiratory and Critical Care Medicine Volume 194 Number 7 | October 1 2016
PULMONARY PERSPECTIVE
Pulmonary Perspective 805
Each computed tomography (CT) technologist form contains proper breathing instructions for a given site’s scanner at the time of scanning the subjects.
The form is made available through the Procedural Verification Software web system and may be downloaded and printed to take to the scanner room or
used for study reference. FOV = field of view; RV = residual volume; TLC = total lung capacity.
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